Blockchain Registration Transaction Record

Synbio Partners for AI Facial Analysis Trial Targeting PTSD & Depression

Synbio International partners with CRO Services for clinical trial of AI facial analysis technology to screen for PTSD and depression. Trial aims for clinical validation of non-invasive mental health screening tool.

This development represents a potential paradigm shift in mental health screening, moving from subjective questionnaires to objective biological data. If clinically validated, this technology could enable earlier detection of conditions like PTSD and depression, leading to more timely interventions and better patient outcomes. For healthcare systems burdened by mental health costs and for employers facing productivity losses, this offers a scalable, non-invasive tool that could transform screening practices. The objective nature of the technology addresses long-standing challenges of stigma and recall bias in mental health assessment, potentially making screening more accessible and consistent across diverse populations.